Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Gain Therapeutics, Inc. (NASDAQ: GANX) shares -made miniscule gains Friday. The Bethesda, Md.-based firm, a clinical-stage biotechnology company leading the discovery and development of the next ...

To fight viruses, bacteria have evolved a way to make new DNA without copying it.

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting ...

At a Senate hearing on Wednesday, Robert F. Kennedy, Jr., referred to ibogaine as the most promising treatment for PTSD and ...

A recently published study from Fred Hutch Cancer Center dramatically expands the number of FDA-approved cancer drugs ...

Antibiotic resistance and antibiotic tolerance have their distinct effect on your system. Knowing their differences is key to ...

Last month marked Women’s History Month, and in February there was International Day of Women and Girls in Science, too. But, ...

Directed evolution has enabled a high-performance biocatalyst to streamline synthesis of the HIV prevention drug lenacapavir ...

Designing molecules is one of chemistry's most complex challenges. From life-saving drugs to advanced materials, each ...

Enzyme assays are essential tools for understanding how enzymes function, from drug discovery to food science. Careful control of assay conditions, awareness of kinetic complexities, and adoption of ...

A protein long understood to drive inflammation by producing nitric oxide has a second, previously unknown role—it physically ...